Akdital S.A (CBSE:AKT)

Market Cap	16.30B -23.3%
Revenue (ttm)	4.41B +49.4%
Net Income	443.68M +41.0%
EPS	n/a
Shares Out	14.16M
PE Ratio	36.73
Forward PE	24.95
Dividend	14.00 (1.22%)
Ex-Dividend Date	Jul 24, 2025

Volume	3,031
Open	1,161.00
Previous Close	1,160.00
Day's Range	1,151.00 - 1,177.00
52-Week Range	975.00 - 1,623.00
Beta	-0.12
Analysts	Strong Buy
Price Target	1,678.50 (+45.83%)
Earnings Date	Jun 25, 2026

About Akdital S.A

Akdital S.A operates in the healthcare sector in Morocco. The company offers its services in the areas of surgical, interventional medicine, critical and intensive care, maternity care, oncology, and diagnostic. It operates private hospitals, multidisciplinary, and specialized clinics and oncology centers. The company was founded in 2011 and is headquartered in Casablanca, Morocco.

• Industry: Hospitals
• Founded: 2011
• Employees: 3,907
• Stock Exchange: Casablanca Stock Exchange
• Ticker Symbol: AKT

Financial Performance

In 2025, Akdital S.A's revenue was 4.41 billion, an increase of 49.40% compared to the previous year's 2.95 billion. Earnings were 443.68 million, an increase of 41.03%.

Analyst Summary

According to 2 analysts, the average rating for AKT stock is "Strong Buy." The 12-month stock price target is MAD 1,679, which is an increase of 45.83% from the latest price.

Price Target

MAD 1,679

(45.83% upside)

Analyst Consensus: Strong Buy